Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Acrocephalosyndactylia × pemigatinib × Clear all

Phase

Phase 2 5 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cholangiocarcinoma 2 Solid Tumor 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Acrocephalosyndactylia 1

Interventions

infigratinib 2 pemigatinib 1 exemestane 1 erdafitinib 1 Fulvestrant 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03235570 2020-05-29

A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)

Incyte Corporation

Phase 1 Completed

Acrocephalosyndactylia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡